Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 105 entries
Sorted by: Best Match Show Resources per page
Mathematical Models of Cancer: When to Predict Novel Therapies, and When Not to.

Bulletin of mathematical biology

Brady R, Enderling H.
PMID: 31338741
Bull Math Biol. 2019 Oct;81(10):3722-3731. doi: 10.1007/s11538-019-00640-x. Epub 2019 Jul 23.

The number of publications on mathematical modeling of cancer is growing at an exponential rate, according to PubMed records, provided by the US National Library of Medicine and the National Institutes of Health. Seminal papers have initiated and promoted...

Cite
Brady R, Enderling H. Mathematical Models of Cancer: When to Predict Novel Therapies, and When Not to. Bull Math Biol. 2019;81(10):3722-3731doi: 10.1007/s11538-019-00640-x.
Brady, R., & Enderling, H. (2019). Mathematical Models of Cancer: When to Predict Novel Therapies, and When Not to. Bulletin of mathematical biology, 81(10), 3722-3731. https://doi.org/10.1007/s11538-019-00640-x
Brady, Renee, and Enderling, Heiko. "Mathematical Models of Cancer: When to Predict Novel Therapies, and When Not to." Bulletin of mathematical biology vol. 81,10 (2019): 3722-3731. doi: https://doi.org/10.1007/s11538-019-00640-x
Brady R, Enderling H. Mathematical Models of Cancer: When to Predict Novel Therapies, and When Not to. Bull Math Biol. 2019 Oct;81(10):3722-3731. doi: 10.1007/s11538-019-00640-x. Epub 2019 Jul 23. PMID: 31338741; PMCID: PMC6764933.
Copy Download .nbib Format: NLM
Progress in surgical oncology: a European perspective. Preface.

Surgical oncology clinics of North America

Nordlinger B.
PMID: 18486877
Surg Oncol Clin N Am. 2008 Jul;17(3):xv-xvi. doi: 10.1016/j.soc.2008.04.016.

No abstract available.

Cite
Nordlinger B. Progress in surgical oncology: a European perspective. Preface. Surg Oncol Clin N Am. 2008;17(3):xv-xvidoi: 10.1016/j.soc.2008.04.016.
Nordlinger, B. (2008). Progress in surgical oncology: a European perspective. Preface. Surgical oncology clinics of North America, 17(3), xv-xvi. https://doi.org/10.1016/j.soc.2008.04.016
Nordlinger, Bernard. "Progress in surgical oncology: a European perspective. Preface." Surgical oncology clinics of North America vol. 17,3 (2008): xv-xvi. doi: https://doi.org/10.1016/j.soc.2008.04.016
Nordlinger B. Progress in surgical oncology: a European perspective. Preface. Surg Oncol Clin N Am. 2008 Jul;17(3):xv-xvi. doi: 10.1016/j.soc.2008.04.016. PMID: 18486877.
Copy Download .nbib Format: NLM
The role of organization in cancer control.

Progress in clinical and biological research

Wilcox FJ.
PMID: 6634744
Prog Clin Biol Res. 1983;132:25-9.

No abstract available.

Cite
Wilcox FJ. The role of organization in cancer control. Prog Clin Biol Res. 1983;132:25-9
Wilcox, F. J. (1983). The role of organization in cancer control. Progress in clinical and biological research, 13225-9.
Wilcox, F J. "The role of organization in cancer control." Progress in clinical and biological research vol. 132 (1983): 25-9.
Wilcox FJ. The role of organization in cancer control. Prog Clin Biol Res. 1983;132:25-9. PMID: 6634744.
Copy Download .nbib Format: NLM
Understanding the Precision in "Precision Medicine".

The oncologist

Chabner BA.
PMID: 27566249
Oncologist. 2016 Sep;21(9):1029-30. doi: 10.1634/theoncologist.2016-0278. Epub 2016 Aug 26.

No abstract available.

Cite
Chabner BA. Understanding the Precision in "Precision Medicine". Oncologist. 2016;21(9):1029-30doi: 10.1634/theoncologist.2016-0278.
Chabner, B. A. (2016). Understanding the Precision in "Precision Medicine". The oncologist, 21(9), 1029-30. https://doi.org/10.1634/theoncologist.2016-0278
Chabner, Bruce A. "Understanding the Precision in "Precision Medicine"." The oncologist vol. 21,9 (2016): 1029-30. doi: https://doi.org/10.1634/theoncologist.2016-0278
Chabner BA. Understanding the Precision in "Precision Medicine". Oncologist. 2016 Sep;21(9):1029-30. doi: 10.1634/theoncologist.2016-0278. Epub 2016 Aug 26. PMID: 27566249; PMCID: PMC5016068.
Copy Download .nbib Format: NLM
Shifting sands: adapting the multidisciplinary team model to technological and organizational innovations in cancer care.

Future oncology (London, England)

Prades J, Borras JM.
PMID: 25396771
Future Oncol. 2014 Oct;10(13):1995-8. doi: 10.2217/fon.14.125.

No abstract available.

Cite
Prades J, Borras JM. Shifting sands: adapting the multidisciplinary team model to technological and organizational innovations in cancer care. Future Oncol. 2014;10(13):1995-8doi: 10.2217/fon.14.125.
Prades, J., & Borras, J. M. (2014). Shifting sands: adapting the multidisciplinary team model to technological and organizational innovations in cancer care. Future oncology (London, England), 10(13), 1995-8. https://doi.org/10.2217/fon.14.125
Prades, Joan, and Borras, Josep M. "Shifting sands: adapting the multidisciplinary team model to technological and organizational innovations in cancer care." Future oncology (London, England) vol. 10,13 (2014): 1995-8. doi: https://doi.org/10.2217/fon.14.125
Prades J, Borras JM. Shifting sands: adapting the multidisciplinary team model to technological and organizational innovations in cancer care. Future Oncol. 2014 Oct;10(13):1995-8. doi: 10.2217/fon.14.125. PMID: 25396771.
Copy Download .nbib Format: NLM
[Oncology: navigating the COVID-19 Pandemic and Steer the Course].

Revue medicale suisse

Zimmermann S, Dietrich PY, Michielin O, Betticher D, Peters S.
PMID: 32348043
Rev Med Suisse. 2020 Apr 29;16:819-822.

Medical oncologists are steering a difficult course during the COVID-19 pandemic between three opposing forces : revisiting optimal standards of cancer care, facing constantly evolving shortages as some resources are being redirected, and acknowledging the paradoxical need to keep...

Cite
Zimmermann S, Dietrich PY, Michielin O, et al. Oncologie : naviguer la pandémie de COVID-19 et garder le cap. [Oncology: navigating the COVID-19 Pandemic and Steer the Course]. Rev Med Suisse. 2020;16:819-822
Zimmermann, S., Dietrich, P. Y., Michielin, O., Betticher, D., & Peters, S. (2020). Oncologie : naviguer la pandémie de COVID-19 et garder le cap. [Oncology: navigating the COVID-19 Pandemic and Steer the Course]. Revue medicale suisse, 16819-822.
Zimmermann, Stefan, et al. "Oncologie : naviguer la pandémie de COVID-19 et garder le cap." [Oncology: navigating the COVID-19 Pandemic and Steer the Course]. Revue medicale suisse vol. 16 (2020): 819-822.
Zimmermann S, Dietrich PY, Michielin O, Betticher D, Peters S. Oncologie : naviguer la pandémie de COVID-19 et garder le cap. [Oncology: navigating the COVID-19 Pandemic and Steer the Course]. Rev Med Suisse. 2020 Apr 29;16:819-822. French. PMID: 32348043.
Copy Download .nbib Format: NLM
Pratiti (Mimi) Bandopadhayay.

The Lancet. Neurology

[No authors listed]
PMID: 34536403
Lancet Neurol. 2021 Oct;20(10):793. doi: 10.1016/S1474-4422(21)00293-3.

No abstract available.

Cite
Pratiti (Mimi) Bandopadhayay. Lancet Neurol. 2021;20(10):793doi: 10.1016/S1474-4422(21)00293-3.
(2021). Pratiti (Mimi) Bandopadhayay. The Lancet. Neurology, 20(10), 793. https://doi.org/10.1016/S1474-4422(21)00293-3
"Pratiti (Mimi) Bandopadhayay." The Lancet. Neurology vol. 20,10 (2021): 793. doi: https://doi.org/10.1016/S1474-4422(21)00293-3
Pratiti (Mimi) Bandopadhayay. Lancet Neurol. 2021 Oct;20(10):793. doi: 10.1016/S1474-4422(21)00293-3. PMID: 34536403.
Copy Download .nbib Format: NLM
Progress in oncology.

Cancer control : journal of the Moffitt Cancer Center

Horton J.
PMID: 12060816
Cancer Control. 2002 May-Jun;9(3):185-6. doi: 10.1177/107327480200900301.

No abstract available.

Cite
Horton J. Progress in oncology. Cancer Control. 2002;9(3):185-6doi: 10.1177/107327480200900301.
Horton, J. (2002). Progress in oncology. Cancer control : journal of the Moffitt Cancer Center, 9(3), 185-6. https://doi.org/10.1177/107327480200900301
Horton, John. "Progress in oncology." Cancer control : journal of the Moffitt Cancer Center vol. 9,3 (2002): 185-6. doi: https://doi.org/10.1177/107327480200900301
Horton J. Progress in oncology. Cancer Control. 2002 May-Jun;9(3):185-6. doi: 10.1177/107327480200900301. PMID: 12060816.
Copy Download .nbib Format: NLM
Surgical oncology.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Burn I.
PMID: 8270034
Eur J Surg Oncol. 1993 Dec;19(6):507-9.

No abstract available.

Cite
Burn I. Surgical oncology. Eur J Surg Oncol. 1993;19(6):507-9
Burn, I. (1993). Surgical oncology. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 19(6), 507-9.
Burn, I. "Surgical oncology." European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology vol. 19,6 (1993): 507-9.
Burn I. Surgical oncology. Eur J Surg Oncol. 1993 Dec;19(6):507-9. PMID: 8270034.
Copy Download .nbib Format: NLM
[Complementary therapies in the hospital: 'if you can't beat them, join them'?].

Nederlands tijdschrift voor geneeskunde

Threels-Eenkhoorn T.
PMID: 11086496
Ned Tijdschr Geneeskd. 2000 Nov 04;144(45):2171-2.

No abstract available.

Cite
Threels-Eenkhoorn T. Complementaire geneeswijzen in het ziekenhuis: 'if you can't beat them, join them'? [Complementary therapies in the hospital: 'if you can't beat them, join them'?]. Ned Tijdschr Geneeskd. 2000;144(45):2171-2
Threels-Eenkhoorn, T. (2000). Complementaire geneeswijzen in het ziekenhuis: 'if you can't beat them, join them'? [Complementary therapies in the hospital: 'if you can't beat them, join them'?]. Nederlands tijdschrift voor geneeskunde, 144(45), 2171-2.
Threels-Eenkhoorn, T. "Complementaire geneeswijzen in het ziekenhuis: 'if you can't beat them, join them'?" [Complementary therapies in the hospital: 'if you can't beat them, join them'?]. Nederlands tijdschrift voor geneeskunde vol. 144,45 (2000): 2171-2.
Threels-Eenkhoorn T. Complementaire geneeswijzen in het ziekenhuis: 'if you can't beat them, join them'? [Complementary therapies in the hospital: 'if you can't beat them, join them'?]. Ned Tijdschr Geneeskd. 2000 Nov 04;144(45):2171-2. Dutch. PMID: 11086496.
Copy Download .nbib Format: NLM
Phase 0 clinical studies in oncology.

Clinical pharmacology and therapeutics

Collins JM.
PMID: 19109589
Clin Pharmacol Ther. 2009 Feb;85(2):204-7. doi: 10.1038/clpt.2008.246. Epub 2008 Dec 24.

No abstract available.

Cite
Collins JM. Phase 0 clinical studies in oncology. Clin Pharmacol Ther. 2008;85(2):204-7doi: 10.1038/clpt.2008.246.
Collins, J. M. (2009). Phase 0 clinical studies in oncology. Clinical pharmacology and therapeutics, 85(2), 204-7. https://doi.org/10.1038/clpt.2008.246
Collins, J M. "Phase 0 clinical studies in oncology." Clinical pharmacology and therapeutics vol. 85,2 (2009): 204-7. doi: https://doi.org/10.1038/clpt.2008.246
Collins JM. Phase 0 clinical studies in oncology. Clin Pharmacol Ther. 2009 Feb;85(2):204-7. doi: 10.1038/clpt.2008.246. Epub 2008 Dec 24. PMID: 19109589.
Copy Download .nbib Format: NLM
[Tumor heterogeneity has considerable importance for the oncology practice].

Versicherungsmedizin

[No authors listed]
PMID: 23593823
Versicherungsmedizin. 2013 Mar 01;65(1):52-3.

No abstract available.

Cite
Tumorheterogenität hat erhebliche Bedeutung für die onkologische Praxis. [Tumor heterogeneity has considerable importance for the oncology practice]. Versicherungsmedizin. 2013;65(1):52-3
(2013). Tumorheterogenität hat erhebliche Bedeutung für die onkologische Praxis. [Tumor heterogeneity has considerable importance for the oncology practice]. Versicherungsmedizin, 65(1), 52-3.
"Tumorheterogenität hat erhebliche Bedeutung für die onkologische Praxis." [Tumor heterogeneity has considerable importance for the oncology practice]. Versicherungsmedizin vol. 65,1 (2013): 52-3.
Tumorheterogenität hat erhebliche Bedeutung für die onkologische Praxis. [Tumor heterogeneity has considerable importance for the oncology practice]. Versicherungsmedizin. 2013 Mar 01;65(1):52-3. German. PMID: 23593823.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 105 entries